-
Pevonedistat hydrochloride by Millennium Pharmaceuticals for Essential Thrombocythemia: Likelihood of Approval
27 Oct 2023 16:35 GMT
… the below form
By GlobalData
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals (Takeda Oncology), a subsidiary …
-
Ixazomib citrate by Millennium Pharmaceuticals for Lymphoblastic Lymphoma: Likelihood of Approval
27 Oct 2023 16:35 GMT
… and graft versus host disease.
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals (Takeda Oncology), a subsidiary …
-
Neurvati Neurosciences Announces Appointment of Deborah Dunsire, MD, as Member and Chair of Company Board of Directors
15 Apr 2024 15:07 GMT
… , CEO and a director of Millennium Pharmaceuticals, Inc. Prior to Millennium, Dr …
-
Pevonedistat hydrochloride by Millennium Pharmaceuticals for Solid Tumor: Likelihood of Approval
10 Feb 2023 09:11 GMT
… is under clinical development by Millennium Pharmaceuticals and currently in Phase I … refractory acute lymphocytic leukemia.
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals is a biopharmaceutical company that …
-
Black Diamond Therapeutics Announces Changes to Board of Directors
11 Apr 2024 12:02 GMT
… roles include Senior Scientist at Millennium Pharmaceuticals and post-doctoral fellow at …
-
Black Diamond Therapeutics Announces Changes to Board of Directors
11 Apr 2024 12:00 GMT
… roles include Senior Scientist at Millennium Pharmaceuticals and post-doctoral fellow at …
-
Multiple Myeloma Market 2032: Epidemiology, Drugs, Pipeline, FDA Approvals and Companies by DelveInsight
26 Mar 2024 12:30 GMT
… , Amgen (Onyx therapeutics), Takeda Pharmaceutical, Millennium Pharmaceuticals, Sanofi, Karyopharm Therapeutic, Janssen Biotech … , Amgen (Onyx therapeutics), Takeda Pharmaceutical, Millennium Pharmaceuticals, Sanofi, Karyopharm Therapeutic, Janssen Biotech …
-
Waldenstrom Macroglobulinemia Market Report 2032: Epidemiology, Therapies, Latest FDA, EMA, Approvals by DelveInsight
03 Apr 2024 10:00 GMT
… AbbVie, Takeda Pharmaceuticals, BeiGene, AstraZeneca, Millennium Pharmaceuticals, Cellectar Biosciences, TG Therapeutics, Gilead … AbbVie
Takeda Pharmaceuticals
BeiGene
AstraZeneca
Millennium Pharmaceuticals
Cellectar Biosciences
TG Therapeutics
…
-
Immune Thrombocytopenia Market Report 2032: Epidemiology, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
27 Mar 2024 12:56 GMT
… Sanofi, Principia Biopharma, Argenx, Millennium Pharmaceuticals, Takeda, Biotest, GC Pharma … BIVV020: Sanofi
TAK-079: Millennium Pharmaceuticals/Takeda
BT-595: … Sanofi, Principia Biopharma, Argenx, Millennium Pharmaceuticals, Takeda, Biotest, GC Pharma …
-
Graft Versus Host Disease Market Size is expected to grow by 2032, according to estimates DelveInsight
26 Mar 2024 07:15 GMT
… (MSD), Regimmune Corporation, Jazz Pharmaceuticals, Millennium Pharmaceuticals/Takeda Oncology, Roche-Genentech … (MSD), Regimmune Corporation, Jazz Pharmaceuticals, Millennium Pharmaceuticals/Takeda Oncology, Roche-Genentech …